Fact CheckerSign in

NCT07866547Not yet recruiting

Off-line Adaptive Proton Therapy

Source: ClinicalTrials.gov · Last updated 8 Oct 2026

Brief summary (registry, in English)

This prospective in-silico study evaluates a novel Off-line Adaptive Proton Therapy (o-APT) workflow for patients with oropharyngeal cancer receiving proton therapy. The study assesses whether automated image analysis, treatment plan adaptation, and quality assurance can identify and prepare treatment plan modifications more efficiently than current clinical practice, without affecting patient care.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
29 Sept 2026
Start date
1 Oct 2026
Primary completion date
31 Jul 2027
Lead sponsor
University Medical Center Groningen
NCT number
NCT07866547

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Oct 2026 to the primary completion date, 31 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Oropharyngeal cancer patients
  • Planned for curatively intended proton therapy
  • Treated with definitive radiotherapy, chemoradiation, or bioradiation
  • Provided informed consent according to Standard Follow-up Program (SFP) for using data for research

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.